Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 409
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01729481 | Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer | ||
| NCT01370772 | Intensified Rituimab Prephase Before FCR in Untreated B-CLL | ||
| NCT01558167 | A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia | ||
| NCT01935492 | 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer | ||
| NCT04671693 | A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. | ||
| NCT02407080 | Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia | ||
| NCT00784446 | First-line Therapy of Stage IV Colorectal Cancer | ||
| NCT01350882 | Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation | ||
| NCT00198146 | Prevention of Diabetes Progression Trial (PDPT) | ||
| NCT05919342 | Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF" | ||
| NCT00752336 | Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation | ||
| NCT00363116 | A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients | ||
| NCT01085838 | Erlotinib in Higher Risk Myelodysplastic Syndrome | ||
| NCT07542678 | Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept | ||
| NCT04059887 | Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY] | ||
| NCT00275548 | Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C | ||
| NCT02666898 | Phase II Trial GA101 Inbrutinib B CLL | ||
| NCT05387616 | A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Copanlisib in Combination With Obinutuzumab in Patients With Previously Untreated Follicular Lymphoma (FL) and a High Tumor Burden | ||
| NCT04661358 | Fenofibrate for Prevention of DR Worsening | ||
| NCT00440167 | Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine | ||
| NCT01817452 | A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol | ||
| NCT03474094 | Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy | ||
| NCT05008081 | The CATALINA Study | ||
| NCT05651724 | Global Research Initiative for Patients Screening on MASH | ||
| NCT00730769 | Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients | ||
| NCT01790633 | Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests | ||
| NCT01953458 | Therapeutic Option for Hepatitis B and C: a French Cohort | ||
| NCT03679455 | A Study of Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobulinemia, OBI-1 | ||
| NCT00485589 | A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM) | ||
| NCT04641676 | A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center | ||
| NCT00938444 | Evaluation of the BRADA and ABILHAND Questionnaires | ||
| NCT00275665 | The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection. | ||
| NCT00552201 | TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic | ||
| NCT02899065 | Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department | ||
| NCT02344472 | Detect V / CHEVENDO (Chemo vs. Endo) | ||
| NCT04059081 | A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment | ||
| NCT02099292 | Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma | ||
| NCT01062555 | Calcineurin Inhibitor Sparing After Kidney Transplantation | ||
| NCT00193609 | Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site | ||
| NCT00944684 | High Dose Ribavirin in the Treatment of Chronic Hepatitis C | ||
| NCT03946358 | Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) | ||
| NCT00201734 | Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary | ||
| NCT01471470 | Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer | ||
| NCT01332929 | Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis | ||
| NCT01847677 | Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin | ||
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | ||
| NCT03691077 | Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714 | ||
| NCT05765084 | Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma | ||
| NCT00952003 | Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients | ||
| NCT02370524 | Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease |
